References
- 1. . Evolutionary and historical aspects of the burden of malaria. Clin. Microbiol. Rev. 15(4), 564–594 (2002).
- 2. Systems analysis and controlled malaria infection in Europeans and Africans elucidate naturally acquired immunity. Nat. Immunol. 22(5), 654–665 (2021).
- 3. . Immunity to non-cerebral severe malaria is acquired after one or two infections. Nat. Med. 5(3), 340–343 (1999).
- 4. A molecular signature in blood reveals a role for p53 in regulating malaria-induced inflammation. Immunity 51(4), 750–765; e10 (2019).
- 5. Molecular profiling reveals features of clinical immunity and immunosuppression in asymptomatic P. falciparum malaria. Mol. Syst. Biol. 18(4), e10824 (2022).
- 6. . Inducible mechanisms of disease tolerance provide an alternative strategy of acquired immunity to malaria. eLife 10, e63838 (2021).
- 7. Metabolic adaptation to tissue iron overload confers tolerance to malaria. Cell Host Microbe 12(5), 693–704 (2012).
- 8. Renal control of disease tolerance to malaria. Proc. Natl Acad. Sci. USA 116(12), 5681–5686 (2019).
- 9. Glucose metabolism mediates disease tolerance in cerebral malaria. Proc. Natl Acad. Sci. USA 115(43), 11042–11047 (2018).
- 10. . Host energy source is important for disease tolerance to malaria. Curr. Biol. 28(10), 1635–1642; e3 (2018).
- 11. Hypothyroidism confers tolerance to cerebral malaria. Sci. Adv. 8(14), eabj7110 (2022).
- 12. Adrenal hormones mediate disease tolerance in malaria. Nat. Commun. 9(1), 4525 (2018).
- 13. Targeting glutamine metabolism rescues mice from late-stage cerebral malaria. Proc. Natl Acad. Sci. USA 112(42), 13075–13080 (2015).
- 14. Dietary restriction protects against experimental cerebral malaria via leptin modulation and T-cell mTORC1 suppression. Nat. Commun. 6(1), 6050 (2015).
- 15. Loss and dysfunction of Vδ2+ γδ T cells are associated with clinical tolerance to malaria. Sci. Transl. Med. 6(251), 251ra117 (2014).
- 16. Systems analysis shows a role of cytophilic antibodies in shaping innate tolerance to malaria. Cell Rep. 39(3), 110709 (2022).
- 17. Exposure-dependent control of malaria-induced inflammation in children. PLoS Pathog. 10(4), e1004079 (2014).
- 18. Plasmodium falciparum malaria drives epigenetic reprogramming of human monocytes toward a regulatory phenotype. PLoS Pathog. 17(4), e1009430 (2021).
- 19. Integrative metabolomics and transcriptomics signatures of clinical tolerance to Plasmodium vivax reveal activation of innate cell immunity and T cell signaling. Redox. Biol. 17, 158–170 (2018).
- 20. Dissecting disease tolerance in Plasmodium vivax malaria using the systemic degree of inflammatory perturbation. PLoS Negl. Trop. Dis. 15(11), e0009886 (2021).